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Function from structure? The crystal structure of human
phosphatidylethanolamine-binding protein suggests a role in
membrane signal transduction
Mark J Banfield*, John J Barker, Anthony CF Perry† and R Leo Brady
Background:  Proteins belonging to the phosphatidylethanolamine-binding
protein (PEBP) family are highly conserved throughout nature and have no
significant sequence homology with other proteins of known structure or function.
A variety of biological roles have previously been described for members of this
family, including lipid binding, roles as odorant effector molecules or opioids,
interaction with the cell-signalling machinery, regulation of flowering plant stem
architecture, and a function as a precursor protein of a bioactive brain
neuropeptide. To date, no experimentally derived structural information has been
available for this protein family. In this study we have used X-ray crystallography to
determine the three-dimensional structure of human PEBP (hPEBP), in an attempt
to clarify the biological role of this unique protein family.
Results:  The crystal structures of two forms of hPEBP have been determined:
one in the native state (at 2.05 Å resolution) and one in complex with
cacodylate (at 1.75 Å resolution). The crystal structures reveal that hPEBP
adopts a novel protein topology, dominated by the presence of a large central
β sheet, and is expected to represent the archaetypal fold for this family of
proteins. Two potential functional sites have been identified from the structure:
a putative ligand-binding site and a coupled cleavage site. hPEBP forms a
dimer in the crystal with a distinctive dipole moment that may orient the
oligomer for membrane binding.
Conclusions:  The crystal structure of hPEBP suggests that the ligand-binding
site could accommodate the phosphate head groups of membrane lipids,
therefore allowing the protein to adhere to the inner leaf of bilipid membranes
where it would be ideally positioned to relay signals from the membrane to the
cytoplasm. The structure also suggests that ligand binding may lead to
coordinated release of the N-terminal region of the protein to form the
hippocampal neurostimulatory peptide, which is known to be active in the
development of the hippocampus. These studies are consistent with a primary
biological role for hPEBP as a transducer of signals from the interior
membrane surface.
Introduction
With the increasing availability of genomic data, novel
proteins of unknown function are frequently being identi-
fied. When no significant sequence similarity to proteins
of known function and structure can be detected, studies
to elucidate the biological role of a protein can be complex
and time-consuming. In contrast, determining protein
crystal structures can now often be almost routine. As a
substantial database of structure/function correlations has
been accumulated, it seems increasingly plausible that
structure determination can be used as a primary tool to
probe and identify biological activity. In the present
study, we illustrate an attempt to identify the biological
function of a novel family of membrane-associated pro-
teins through crystal structure determination.
In the mid 1980’s a number of related, but novel,
soluble cytosolic proteins were reported that shared an
affinity for hydrophobic ligands (reviewed in [1]).
Among these was a 23 kDa basic cytosolic protein from
bovine brain [2]; this protein was later described as
phosphatidylethanolamine-binding protein (PEBP) after
binding studies indicated a preference for binding this
lipid compared to other phospholipids [3]. Subse-
quently, PEBP has been identified in a wide range of
mammalian tissues, including brain, liver, spleen,
stomach and muscle from human, cow, rat and chicken
(and also sheep brain) [4], with histochemical staining
studies frequently showing localisation to the inner
periplasmic membrane. Database searches with the
amino acid sequences of PEBPs [5] revealed no
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significant sequence similarity with other proteins, sug-
gesting that these proteins may be both functionally and
structurally unique.
Over the past ten years a number of proteins have been
isolated and assigned to the ‘PEBP family’ on the basis of
sequence homology. These include further mammalian
homologues to those listed above (monkey [6] and mouse
[7]), and homologues from fly (Drosophila melanogaster [8]),
yeast (Saccharomyces cerevisiae [9]), a malarial parasite (Plas-
modium falciparum [10]), nematode worms (Onchocerca
volvulus [11] and Toxocara canis [12]), and flowering plants
(Antirrhinum [13] and Arabidopsis thaliana [14]). As PEBP
homologues are found in such a diverse range of species,
this implies that the protein may be performing an essen-
tial biological role. In mammalian cells, PEBP has been
suggested to have a role in organising membrane domains
or in membrane biogenesis [5,6]. PEBP has been impli-
cated in this role on the basis of its affinity for phospho-
lipids (specifically phosphatidylethanolamine) and its
high level of expression in rapidly growing cells, such as
testes [15] and brain oligodendrocites [16]. Although this
may be one function of the protein, the isolation of
PEBPs from other species suggest alternative functions.
The Drosophila homologues were isolated as putative
odorant-binding proteins, and have an N-terminal signal
sequence directing secretion into the lumen of the
olfactory hairs [8]. The nematode homologues are
frequently found in membranous material shedded by
these worms and have been suggested to shield the
worms from detection by the host immune system during
infection [12]. These nematode forms of PEBP also have
an N-terminal signal sequence for secretion, and the
protein from Toxocara canis has an additional 72 amino
acid N-terminal extension comprising two 36-residue,
six-cysteine NC-6 (nematode (Cys)6) motif [12] of
unknown function.
Intriguingly, the yeast homologue TFS1 has been
described as a dosage-dependent suppressor of CDC25
mutations [9]. The CDC25 gene product has been impli-
cated in GDP/GTP exchange of ras proteins, suggesting
that PEBPs may participate in cellular signalling path-
ways. Bovine brain PEBP has been reported to bind
various nucleotides including GTP and GDP, as these
nucleotides have been shown to elute the protein from an
affinity column [17]. Direct GTP binding to PEBP,
however, could only be measured by autoradiography
when PEBP was incubated in the presence of other GTP-
binding proteins [17], concluding that PEBP may specifi-
cally interact with small GTP-binding proteins. A
signalling role is also implied in the flowering plants,
where the PEBP homologue appears to control a switch
between determinant and indeterminant inflorescence in
the apical meristem [13].
Finally, purification of rat hippocampal cholinergic
neurostimulating peptide (HCNP), an 11 amino acid
peptide that enhances acetylcholine synthesis in rat
brain [18], revealed an amino acid sequence identical to
residues 2–12 of rat PEBP. The equivalent peptide in
humans is also identical in sequence to the N terminus of
hPEBP, despite sequence differences in five positions
between the rat and human HCNPs. It therefore seems
extremely likely that PEBP is the precursor protein 
of HCNP, although whether this is a secondary function
of the protein or related to its lipid-binding role is
unclear. A (potentially) specific protease has also been
isolated that may cleave PEBP to yield the bioactive
peptide [19].
Despite the widespread presence and characterisation of
PEBPs from different species, the enigma of the function
of these proteins remains to be fully resolved. Whether
they have the same overall function in all species, or
perform a variety of roles remains unclear. The ability of
the protein to interact with the cell-signalling machinery
(GTP-binding proteins), its apparent location in regions
of cell growth (testes, developing brain, inflorescence
meristem of flowering plants), and ability to bind biologi-
cal membranes, implies that these proteins may be
involved in the modification of membrane structures
during cell growth, or may act as messengers between the
cell membrane and the cytosol. The other functions
assigned to the protein, such as odorant binding, which
occurs outside the cell membrane, are more difficult to
quantify aside from this family’s ability to bind hydro-
phobic ligands.
There have been no previous reports of structures of pro-
teins from the PEBP family. A homology model of bovine
brain PEBP has been constructed on the basis of
hydrophobic cluster analysis and the crystal structure of
the N-terminal domain of yeast phosphoglycerate kinase
[20]. This model suggested a putative nucleotide-binding
site between residues 112–125, which had homology with
the βαβ Rossmann fold nucleotide-binding motif [20].
Circular dichroism studies in our own laboratory indicated
a mixture of α helices and β sheets within the protein
(data not shown).
In an attempt to clarify the biological functional of this
unique protein family we have determined the crystal
structure of a recombinant form of human PEBP
(hPEBP) in its native form to 2.05 Å resolution, and in
complex with cacodylate to 1.75 Å resolution. This first
structure of a protein from the PEBP family reveals a
novel fold topology, and identifies two regions likely to
be crucial for its biological function. These studies
represent an early attempt to use crystal structure
determination as a tool to identify the biological role of a
novel protein.
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Results and discussion
The overall structure of hPEBP
hPEBP crystallises with two molecules in the asymmetric
unit. For one of these molecules, 180 residues could be
modelled (chain A, Leu5–Leu185); for the other molecule
185 residues (chain B, Pro2–Gly186) could be modelled.
The overall structure of hPEBP is shown in Figure 1. The
electron density is continuous across the whole sequence
(representative sections are shown in Figure 2).
The functional oligomeric state of hPEBP (and other
PEBPs) is unknown, although there is some evidence to
suggest that the protein can form dimers and higher
oligomers [1]. In the crystal structure there is an approxi-
mate twofold noncrystallographic axis between the two
molecules of the asymmetric unit (related by a 177.4° rota-
tion). The two molecules are virtually identical, with a
root mean square deviation (rmsd) between equivalent Cα
positions of 0.26 Å. Some evidence for the dimerisation of
PEBP in solution has been observed from gel elec-
trophoresis and fluorescence studies (data not shown),
implying that the dimer observed in the crystal (see
Figure 3a) may represent the functional form of the
protein. This idea is further supported by the considerable
solvent-accessible surface area buried between the two
monomers in the dimer (1453 Å2, calculated with the
program Quanta).
The structure of hPEBP comprises four α helices and nine
β strands (Figures 1 and 3). A dominant feature of the
structure is the central six-stranded β sheet (βC, βJ, βI,
βF, βG and βH). This β sheet comprises four antiparallel
main strands bordered on either side by two short
strands — one parallel (βC) and one antiparallel (βG). The
remaining three β strands in the structure (βB, βA and βE)
form a small antiparallel β sheet which partially packs
against one corner of the larger sheet. (It should be noted
that β strands are labelled so as to correspond to
immunoglobulin/fibronectin type III conventions, thus
enabling the discussion below.) Of the four α helices, one
is formed at the N terminus (αA) and one at the C termi-
nus (αD). The two other helices (αB and αC) pack on
either side of the main β sheet. Database searches with
the structure of hPEBP using a variety of software pack-
ages (including DALI [21] and DEJAVU [22]) indicate
that the fold is distinct from any currently identified
protein family. There is some very limited similarity
between the two β-sheet regions and standard
immunoglobulin/fibronectin type III folds. In PEBP,
however, the β barrel is not completed, and the arrange-
ment of strands comprising the sheets differs consider-
ably. Whereas in immunoglobulin/fibronectin type III
folds the sheets are composed of strands conventionally
called A-B-E and G-F-C-C′, the arrangement within the
equivalent PEBP sheets is B-A-E and H-G-F-I-J-C,
respectively (see Figure 3). This observation implies that
the PEBP fold is a distinct unit rather than an evolved
form of the immunoglobulin domain with considerable
insertions and deletions. Attempts were also made to iden-
tify smaller segments of the fold that may have similarity
to previously identified structural motifs (using the pro-
grams RIGOR and SPASM [23]), but no conclusive, sig-
nificant homology was found.
Two long loops on the surface of the protein, one from
residues 104–118 (between βH and βI) and the second
from residues 127–150 (between βI and αC), form a
notable feature of the structure. These loops are very well
ordered within the crystals, refining with temperature
factors comparable to the remainder of the protein. The
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Figure 1
Stereoview diagram showing the Cα trace of
the hPEBP monomer. Every tenth amino acid
residue is labelled; the N and C termini are
marked.
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long loop between βI and αC forms the majority of the
putative dimer interface (see Figure 3a), which may
explain its stability.
There are two cis peptide bonds per monomer formed by
Pro74 and Glu83. The cis orientation of the Glu83 peptide
bond and the positions of the surrounding sidechains are
very well defined in the electron density and were refined
without manual intervention. The unfavourable orienta-
tion is presumably stabilised by interactions with the rest
of the protein. There are extensive hydrogen-bonding
interactions in this area. Nonproline cis peptides are very
rare in protein structures and are commonly associated
with ligand binding or the positioning of active-site
residues [24]. The interactions of the cis Glu83 peptide
bond with a putative binding/active site for hPEBP are
discussed below.
Surface charge calculations did not immediately suggest a
region of the molecule that could account for the reported
binding to membranes and phospholipids. However, both
the dimer and monomer exhibit a very pronounced dipole
moment (288 and 174 debye, respectively, calculated with
Quanta) oriented approximately in the plane of the page
and in the direction shown in Figure 3a. The overall posi-
tive charge in this direction would direct this face of the
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Figure 2
Stereoview diagrams showing the quality of
the electron-density map. (a) REFMAC-
weighted 2Fobs–Fcalc·φcalc electron-
density map generated using the final model
of hPEBP (soaked native data), contoured at
1.2σ. The electron density is representative of
the overall quality of the map and shows
residues His118 (top) to Trp122 (bottom).
(b) The equivalent region from the multiple
isomorphous replacement (MIR) electron-
density map (after density modification and
noncrystallographic symmetry averaging). This
map was used to build the initial model.
protein towards the negatively charged inner leaf of the
plasma membrane, and hPEBP is likely to bind to the
membrane in the orientation indicated in Figure 3a.
Sequence comparison of PEBP family members
An amino acid sequence alignment of a selection of pro-
teins from the PEBP family is shown in Figure 4.
Members of the family exhibit two main regions of high
sequence conservation, residues 64–91 and residues
111–123 (hPEBP numbering). Amino acid residues that
are fully conserved in all members of the family are
71–72, 74, 86 and 119. Residues 71–72 and 74 form part
of an Asp-Pro-Asp-x-Pro motif that is universally con-
served in all members of the family, except for the
Drosophila homologue where the first aspartic acid
residue (Asp70) is substituted with a cysteine. Arg119 is
part of a second highly conserved region running from
residues 116–119, with motif Gly-x-His-Arg. The strong
conservation in these regions implies a biological role, as
discussed below.
There are only two significant insertions/deletions appar-
ent from sequence comparison. Firstly, the Toxacara canis
sequence has an additional 60 residues at the N terminus
(not shown in Figure 4). This is currently the only known
member of the family with this extension. Secondly, the
yeast homologue has a 17 amino acid insertion between
residues 105 and 106 (hPEBP numbering). This insertion
lies in one of the loops present in the structure, connect-
ing βH and βI in the hPEBP structure, and is thought
unlikely to disrupt the overall fold of the protein.
Putative ligand-binding sites
One obvious feature of the PEBP structure is a binding
pocket located at one end of the central β sheet, adjoining
the putative membrane-binding face. Several lines of evi-
dence support the notion that this region is a biologically
important ligand-binding site. Firstly, diffraction data
from crystals grown and frozen in the presence of
cacodylic acid exhibit pronounced electron density within
this pocket; this density has been modelled as a molecule
of cacodylate (see Figure 5a). Arsenate is frequently used
as a mimic of phosphate groups, and it is likely that the
derivatised form of arsenate in cacodylate could indicate
the mode of phosphate binding in this region. The
cacodylate group makes specific interactions with the
protein to which it is bound via four hydrogen bonds and
van der Waals interactions.
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Figure 3
Secondary structure elements in hPEBP. (a) The putative dimer of
hPEBP formed by the two molecules in the asymmetric unit of the
crystal. Also shown (arrow) is the approximate direction of the dipole
moment for the hPEBP dimer, which suggests an orientation for the
oligomer to interact with the membrane. The molecules of cacodylate
present in the ligand-bound structure are shown in CPK
representation. (b) Schematic topology diagram illustrating the
arrangement of secondary structure in the hPEBP monomer. β Strands
(shown in cyan) are labelled with lower-case letters and correspond to
immunoglobulin/fibronectin type III conventions, as discussed in the
text; α helices (shown in red) are labelled with upper-case letters. (The
figures were prepared using the program MOLSCRIPT [32] and
rendered using Raster3D [33].)
Secondly, the two regions of high sequence conservation
(residues 65–91 and 111–123) discussed above are inti-
mately involved in determining the local structure at this
site. The universally conserved His86 (hPEBP number-
ing) lies at the base of the pocket, along with Asp70, the
first aspartic acid residue of the Asp-Pro-Asp-x-Pro motif.
Residues 69–75, which include cis Pro74, line one side of
the putative binding site. The third conserved region,
comprising residues 111–123, forms part of a second side
of the binding pocket and a loop adjacent to this site.
The cis peptide bond formed by Glu83 is also located in
this region. As nonproline cis peptides are rare and tend
to be associated with maintaining the structure of active
sites or directly binding to ligands, this observation adds
further support to the idea that this region has an impor-
tant functional role. Furthermore, the site is located at
the apex of the calculated dipole moment for the mol-
ecule, as would be expected for binding to the negatively
charged membrane.
The combination of all of these features strongly impli-
cate this region as an important ligand-binding site for
PEBP. This may not, of course, be the only important
region of the protein. If this region is involved in binding
to the membrane, as suggested by the the dipole moment
of the dimer, there may by other regions that carry out a
cytosolic function.
Access to the putative ligand-binding site appears to be
regulated, at least in part, by the location of the C-terminal
α helix, αD. In the crystal structure, this helix packs adja-
cent to the entrance of the ligand-binding site. The
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Figure 4
                                            < αA >             < βA >  < βB >  < < βC >  < αB >  
Human                                   PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGA...AVDELGKVLTPTQVKNRPT.S  52
Monkey                                  PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGA...ALDELGKVLTPTQVKNRPT.S  51
Cow                                     PVDLSKWSGPLSLQEVDERPQHPLQVKYGGA...EVDELGKVLTPTQVKNRPT.S  51
Rat                                    MAADISQWAGPLSLQEVDEPPQHALRVDYGGV...TVDELGKVLTPTQVKNRPS.S  52
Dros      MKLPALHLLFLGYICLARSQDNDENVRRIMK.....EMEVIPEIL.DEPPRELLRIKYDNT...IDIEEGKTYTPTELKFQP..R  74
OV16    MHCLQVVIAIVLYSFGKISAENANCKKCTPMLVDSAFKEHGIVPDV.VSTAPTKLVNVSYNN....LTVNLGNELTPTQVKNRPT.K  82
Toxc  DEANNCAASINLCQNPTFEPLVRDRCQKTCGLCAGCGFISSGIVPLV.VTSAPSRRVSVTFANN...VQVNCGNTLTTAQVANQPT.. 120
CEN                               MAAKVSSDPLVIGRVIGDVVDHFTSTVKMSVIYNSNNSIKHVYNGHELEPSAVTSTP..R  58
Plasf                   MTIPTISELKKDRIIPHVFPNDKIDLNVDLFISFKAGKEVNHGNVLDIAGTGSVPRNIKFSEEPPDGYC..  68
Yeast             MNQAIDFAQASIDSYKKHGILEDVIHDTSFQPSGILAVEYSSSAPVAMGNTLPTEKARSKPQFQFTFNKQMQKSVPO  77
       βE>      <   βF   >             <   βG   >      < βH βI>                              < 
Human  ISWDGLDSGKLYTLVLTDPDAPSRKDPKYREWHHFLVVNMKGNDISSGTVLSD..................YVGSGPPKGTGLHRYVW 122
Monkey ISWDGLDSGKLYTLVLTDPDAPSRKDPKYREWHHFLVVNMKGNDISSGTVLSD..................YVGSGPPKGTGLHRYVW 121
Cow    ITWDGLDPGKLYTLVLTDPDAPSRKDPKYREWHHFLVVNMKGNDISSGTVLSD..................YVGSGPPKGTGLHRYVW 121
Rat    ISWDGLDPGKLYTLVLTDPDAPSRKDPKYREWHHFLVVNMKGNDISSGTVLSE..................YVGSGPPKGTGLHRYVW 122
Dros   LDWNA.DPESFYTVLMICPDAPNRENPMYRSRLHWLVVNVPGLDIMKGQPISE..................YFGPLPPKDSGIQRYLI 143
OV16   VSWDA.EPGALYTLVMTDPDAPSRKNPVFREWHHWLIINISGQNVSSGTVLSD..................YIGSGPRKGTGLHRYVF 149
Toxc  VTWEA.QPNDRYTLIMVDPDFPSAANGQQGQRLHWWVINIPGNNIAGGTTLAA..................FQPSTPAANTGVHRYVF 211
CEN  VEVHGGDMRSFFTLIMTDPDVPGPSDPYLREHLHWIVTDIPGTTDSSFGK.EV..................VSYEMPRPNIGIHRFVF 126
Plasf  ...........FVLFMVDPDYPSRLRPDGKEYIHWVVSGIKTKELIKGTQKNCVTILP.............YVGPSIKKGTGLHRISF 133
Yeast  ANAYVPQDDDLFTLVMTDPDAPSKTDHKWSEFCHLVECDLKLLNEATHETSGATEFFASEFNTKGSNTLIEYMGPAPPKGSGPHRYVF 165
        βI  >                      <     αC     >   <   βJ   >   <    αD    >
Human  LVYEQDRPL.KCDEPILSNRSGDHRGKFKVASFRKKYELRAPVAGTCYQAEWDDYVPKLYEQLSGK    187
Monkey LVYEQARPL.KCDEPILSNRSGDHRGKFKVASFRKKYELGAPVAGACYQAEWDDYVPKLYEQLSGK    186
Cow    LVYEQEGPL.KCDEPILSNRSGDHRGKFKVASFRKKYELGAPVAGTCYQAEWDDYVPKLYEQLSGK    186
Rat    LVYEQEQPL.NCDEPILSNKSGDNRGKFKVESFRKKYHLGAPVAGTCFQAEWDDSVPKLHDQLAGK    187
Dros   LVYQQSDKL.DFDEKKMELSNADGHSNFDVMKFTQKYEMGSPVAGNIFQSRWDEYVPELMKTLYGVSE  210
OV16   LVYKQPGSITDTQH.......GGNRRNFKVMDFANKHHLGNPVAGNFFQAKHED                199
Toxc  LVYRQPAAINSPLLNNLVVQ.DSERPGFGTTAFATQFNLGSPYAGNFYRSQA                  264
CEN LLFKQKKRGQAMLSPP.....VVCRDGFNTRKFTQENELGLPVAAVFFNCQRETAARRR           182
Plasf  IISLIKEEDKDNITGLPHYKGEKYITRVKFNNYESVHNIAQINNMKIVGYNWCQIEG             190
Yeast  LLY....KQPKGVDSSKFSKIKDRPNWGYGTPATGVGKWAKENNLQLVASNFFYAETK            221
Structure
Sequence alignment for a selection of members of the PEBP family.
The sequences of PEBP homologues from human, monkey, cow, rat,
Drosophila, Onchocerca volvulus antigen 16 (OV16), Toxocara canis
TES26 (Toxc), Antirrhinum (CEN protein), Plasmodium falciparum
(Plasf) and yeast (DKA-1 protein) are shown. The figure is based on an
alignment of all the PEBP sequences found by searching sequence
databases (conceptually translated proteins were not included). The
location of the secondary structure elements of the hPEBP structure
are shown. Residues are colour-coded: red, conserved residue identity
in > 90% of the whole family; magenta, conserved as Phe/Tyr,
Leu/Met, Ile/Val, Asn/Asp/Gln/Glu in > 90% of the whole family;
purple, conserved identity in > 50% of the whole family. It should be
noted that the Toxocara canis homologue contains a further 60 amino
acid residues at the N terminus to those shown here. (The alignment
was produced using the program MULTALIN [34].)
α helix is amphipathic and presumably adopts this confor-
mation to bury its hydrophobic residues. In solution,
however, either in the native and/or any ligand-bound
state, αD may be mobile and able to rotate away from the
protein. This would greatly enhance access to the putative
ligand-binding site. Given the location of this helix on the
potential membrane-binding surface of the protein, it is
also possible that αD may insert into the membrane
during binding. If movement of αD is important in mem-
brane/ligand binding this would explain our inability to
date to observe complexes of hPEBP with phospholipid
head group mimics (such as glycerol-3-phosphate), as relo-
cation of the helix is restricted by packing within the
crystal environment. From the conformation of the
binding site observed in the crystals, it is not obvious how
discrimination for phosphatidylethanolamine over other
head groups would be achieved. Alterations associated
with the relocation of helix αD might provide the neces-
sary specificity, however.
Does the structure of hPEBP indicate its biological role?
The sequence of bovine brain PEBP suggested that the
protein contained an ATP-binding consensus sequence of
Arg/Lys-x-x-Gly-x-x-x-(hydrophobic)4-x-x-Asp/Glu [20],
comprising residues 112–125. In the PEBP model [20],
part of this sequence (residues 119–125) formed the final
β sheet of a βαβ Rossmann fold nucleotide-binding motif.
Although the crystal structure does confirm that residues
119–125 do indeed form a β sheet, there is no further con-
servation of the standard nucleotide-binding motif. There
is no α helix or first β sheet, and if this region is involved
in nucleotide binding it must be significantly different to
that commonly found.
A role for PEBP in organising or assembling membranes
has previously been suggested [5,6]. Although the struc-
ture supports membrane localisation, it seems unlikely
that PEBP acts as a phospholipid transporter. A lipid
carrier would need to accommodate and protect the
hydrophobic component of its ligand, and there are no fea-
tures in the PEBP structure that appear capable of this
role. The affinity of PEBP for phospholipids, together
with the prominent dipole moment and location of the
ligand-binding site, instead strongly imply that the protein
uses these features for binding and localisation to the
inner membrane surface. This suggestion is supported by
immunochemical staining studies which show that PEBP
can concentrate on the inner membrane [1]. Binding could
either be through direct interaction of the protein with the
phosphate head groups of the membrane lipid — as mim-
icked by the cacodylate group — or via chelated metal
ions. In two of the heavy-atom derivatives used in deter-
mining the initial phases there was a common binding site
within the pocket. Protein–metal–phosphate interactions
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Figure 5
Putative active-site arrangements in hPEBP.
(a) Stereoview diagram showing the binding
of cacodylate within the putative
active/binding site of hPEBP. Omit-style
electron-density map (red, REFMAC-weighted
Fobs–Fcalc·φcalc) showing the density into
which the cacodylate molecule (also shown)
has been modelled. This molecule of
cacodylate was omitted from the refinement
before map calculation. The electron density
around the protein (blue) is the final
2Fobs–Fcalc·φcalc, as shown in Figure 2. 
(b) Orientation of the amino acids that may be
involved in the cleavage of residues 2–12 of
hPEBP to yield the bioactive peptide HCNP.
Atoms are shown in standard colours. (The
figure was prepared using the program
GRASP [35].)
are observed in many protein–DNA complexes and could
provide a mechanism for indirect interaction between the
ligand-binding site and the phosphate of membrane lipids.
Rat and human PEBP appear to be the precursor proteins
for the neurostimulatory peptide HCNP, which corre-
sponds to residues 2–12 of hPEBP. In the crystal structure
this region is exposed on the surface of the protein, in both
the monomer and dimer, with part of the sequence
forming the first α helix, αA. This conformation leaves
both the peptide and its cleavage site accessible to any spe-
cific protease that may interact with PEBP and cleave the
bioactive peptide from the protein. However, within the
crystal structure Arg119, which is universally conserved in
the PEBP family, forms a hydrogen bond with the carbonyl
group of the scissile peptide bond (Leu12–Ser13) that
would be cleaved to generate HCNP (see Figure 5b) and
may activate the bond for autocleavage. Arg119 also makes
contacts with three residues in the putative phosphate-
binding site: Asp72 (the universally conserved second
aspartate residue of the Asp-Pro-Asp-x-Pro motif), which
makes a strong salt bridge contact; His118 (conserved in all
but one member of the family); and Tyr120. Finally, the cis
orientation of the peptide bond between Arg82 and Glu83
locates the sidechain of Arg82 in the region of potential
cleavage. Together, these features suggest that there may
be a mechanism for autocatalysis to release the bioactive
peptide, and that this might be activated through confor-
mational changes associated with ligand binding. Cleavage
of the peptide has not been observed in recombinant
samples of hPEBP produced in bacteria, supporting the
notion that if autocatalysis does take place there is a
requirement for coordination with ligand binding or a spe-
cific biochemical environment.
Biological implications
Human phosphatidylethanolamine-binding protein
(hPEBP) is an archaetypal member of a widespread
family of membrane-associated proteins related by exten-
sive amino acid homology. These proteins are found in a
wide variety of neural, peripheral, reproductive and other
tissues, but have yet to be ascribed a clear biological role.
A variety of ligands have been reported to bind to
members of this family, including phospholipids, opioids,
hydrophobic odorant molecules and possibly G protein
coupled signalling proteins. In addition, the development
of flowering plant stem architecture is associated  with the
presence of a PEBP, and a bioactive peptide derived from
mammalian forms of PEBP has been reported to regulate
development of the hippocampus. We have determined
here the structure of hPEBP in an attempt to clarify the
biological role of this protein family, which despite previ-
ous biochemical studies has remained inconclusive.
This first crystal structure of a member of the PEBP
family has revealed a novel protein topology, and all other
members of the family are expected to adopt a similar
fold. From the structure, a ligand-binding site has been
identified. This binding site could accommodate the phos-
phate head groups of membrane phospholipids and hence
attach the protein to the inner membrane surface, which
is rich in phosphatidylethanolamine. Such an interaction
would locate the protein in an ideal position to relay
signals from the membrane to the cytoplasm, either
directly or through other, as yet unidentified, signalling
partners. Although the crystal structure has not provided
a direct function for this novel family of proteins, sugges-
tions that the protein has a signalling role are fully sup-
ported by the membrane-association model. The structure
also provides a plausible link between ligand binding and
coordinated release of the hippocampal cholinergic neu-
rostimulating peptide, an activity not previously related to
other suggested functions.
Materials and methods
Cloning, expression and purification
hPEBP was cloned into the pET15b vector and the recombinant
plasmid was used to transform Escherichia coli BL21 cells. hPEBP was
overexpressed by induction of an E. coli culture with 1 mM isopropyl-β-
D-thiogalactopyranoside (IPTG), and the cells were harvested after 4 h.
Cells were lysed by sonication and the resulting supernatant, post-cen-
trifugation, was passed through a Ni2+ chelating column precharged
with nickel sulphate. hPEBP binds to the column as it is expressed with
a histidine-tag at the N terminus. The protein was then eluted with a
linear gradient of imidazole. The His-tag was removed with thrombin and
the resulting protein solution passed through a benzamidine-chelating
column (to remove thrombin), and a second Ni2+ chelating column (to
remove uncleaved hPEBP). Fractions containing protein that did not
bind to either column were confirmed to be hPEBP by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS–PAGE).
Crystallisation and heavy-atom derivatives
Purified hPEBP was concentrated to 5 or 10 mg/ml and buffer-
exchanged to 5 mM Bis-Tris, pH 6.5 (0.01% sodium azide) by ultra-
filtration. Initial crystallisation conditions for hPEBP were identified from
the Hampton screen kit [25]. For data collection, crystals were grown
from a 1:1 ratio of hPEBP protein solution and precipitant solution
containing 28–32% polyethylene glycol (PEG) 4000/6000/8000,
200–300 mM sodium acetate, 0.01% sodium azide, buffered at pH 6.5
with 100 mM sodium cacodylate. Identical crystals were obtained from
each of the PEG solutions and from the range of sodium acetate used.
3 µl: 3 µl drops (protein: precipitant) were typically used.
The crystal structure of hPEBP was solved by multiple isomorphous
replacement (MIR) methods using three derivatives. Heavy atoms were
introduced into the crystals by soaking in the respective precipitant solu-
tion but with 34% PEG 4000/6000 or 32% PEG 8000 and the cacody-
late buffer replaced by 100 mM Bis-Tris. For the uranium and mercury
derivatives, crystals were soaked for 8 h in 2 mM uranium acetate or
1 mM mercuric acetate, respectively. For the platinum derivative, crystals
were soaked overnight in 2 mM potassium platinum nitrate.
Data collection and the initial electron-density map
Two native data sets of hPEBP were collected, one with the crystal
soaked in 34% PEG 4000, 200 mM sodium acetate, 100 mM Bis-Tris
(pH 6.5) for 8 h (‘soaked’ native data), and one transferred to 34%
PEG 4000, 200 mM sodium acetate, 100 mM sodium cacodylate
(pH 6.5) and mounted immediately. These solutions served as
cryoprotectants. Both native data sets were collected at 100K on a MAR
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(SRS), station PX7.2 operating at λ = 1.488 Å. For data collection statis-
tics and analysis, see Table 1. hPEBP crystallises in monoclinic space
group P21 with unit-cell dimensions a = 45.4 Å, b = 61.6 Å, c = 67.9 Å,β = 101.1°. On soaking of the crystals in Bis-Tris buffer a slight unit-cell
change is observed, therefore dimensions for the native soaked data are
a = 45.4 Å, b = 60.7 Å, c = 67.6 Å, β = 102.4°. This soaked native data
was essential to maintain isomorphism with the heavy-atom derivative
crystal soaks. There are two molecules in the asymmetric unit.
Data in this project were processed with DENZO and scaled with
SCALEPACK [26], all further processing used programs within the
CCP4 suite [27]. Data for the uranium and platinum derivatives were
collected on a DIP2000 image plate using nickel-filtered CuKα radia-
tion from an Enraf-Nonius FR-591 rotating-anode generator. The
mercury derivative was collected at the Daresbury SRS (other details
as above). For data collection statistics, see Table 1.
Heavy-atoms positions were refined in MLPHARE [27] using data to
2.5 Å resolution, and initial protein phases were calculated. All struc-
ture determination used the soaked native data. For statistics on heavy-
atom refinement see Table 1, the final figure of merit from MLPHARE
was 0.54. The initial protein phases were then subject to modification
with DM [27] and extended to 2.2 Å resolution.
Model building and refinement
All model building was performed using the program O [28]. The first
electron-density map to 2.2 Å resolution was of high quality.
Skeletonisation of the electron density with the BONES procedure
[22] and subsequent editing enabled a number of secondary structure
elements to be identified, and manual overlaying of the two molecules
in the asymmetric unit revealed a noncrystallographic symmetry (NCS)
relationship. This relationship was further refined with the Uppsala IMP
program [22] using a mask generated in MAMA [22]. DM and the
MAMA mask were then used to average the phases and further refine
the NCS matrix. The resulting map from this procedure was very good
and used to build in an initial model comprising a continuous sequence
from residues 8–29 and 49–183.
All refinement of the hPEBP structure was performed with REFMAC
[27]. The first round of refinement of the initial model to 2.05 Å (with
tight NCS restraints) produced an Rcryst = 33.4% and Rfree
[29] = 35.5%. The resulting maps enabled building of the sequence
between residues 29 and 49. During subsequent rounds of refinement,
NCS restraints were released for sidechains which clearly adopted dif-
ferent conformations. Repeated cycles of rebuilding in O and refine-
ment with REFMAC, with addition of water molecules using ARPP
[26], lowered the Rcryst to a final value of 17.1% and Rfree to 23.2%,
with an rmsd for bond lengths of 0.008 Å and for angles 0.025 Å
(1.6°). For a summary of refinement statistics, see Table 2. A
Ramachandran plot [30] for the structure of hPEBP is shown in
Figure 6, 331 residues out of 333 are within ‘core’ regions [31]. The
conformation of the two ‘outliers’ — residue Asp72 from both the A and
B chains — is very well defined in the electron density.
The final model generated from the 2.05 Å soaked data was then used
to solve the data collected to 1.7 Å. Two molecules were positioned
using AMoRe. Refinement (REFMAC) and model building (O) to date
has lowered Rcryst to 23.5% and Rfree to 28.7%, with rmsds for bond
lengths and angles of 0.008 Å and 0.025 Å (1.6°), respectively. This
model is essentially identical to the model refined against the soaked
native data apart from the presence of a bound cacodylate molecule in
each monomer. In addition, in the electron-density maps near the puta-
tive ligand-binding site of one of the monomers there is a substantial
amount of additional density that we have been unable to account for.
This density is consistent with a loosely associated ligand (not cova-
lently bound to the protein), and is thought to be the most likely reason
that the R factors for this model remain relatively high.
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Table 1
Data collection and phasing statistics for hPEBP*.
Native (soaked) Cacodylate-bound Uranium acetate Mercuric acetate Potassium platinum 
nitrate
dmin (Å) 2.05 (2.14–2.05) 1.7 (1.76–1.70) 2.0 (2.15–2.00) 2.0 (2.09–2.00) 2.0 (2.09–2.00)
No. of unique reflections 23 508 38 803 24 033 23 839 23 829
Redundancy 3.5 2.4 2.7 2.8 3.5
Completeness (%) 100 (100) 95.6 (94.9) 98.4 (96.0) 95.0 (83.3) 96 (85.2)
Rmerge 5.8 (12.0) 5.5 (28.0) 7.4 (15.4) 7.0 (14.8) 9.2 (27.9)
(I)/σ(I) 22.3 (9.8) 16.2 (2.6) 13.3 (5.1) 14.8 (6.0) 12.1 (3.7)
dmin (for phasing) (Å) 2.5 2.5 2.5
Riso (%) 19.6 23.7 8.3
Phasing power
centric/acentric 1.3/1.74 0.89/1.31 0.48/0.91
Rcullis
centric/acentric 0.65/0.69 0.8/0.79 0.88/0.91
*Numbers in parentheses represent the values for the highest resolution shell.
Table 2
Refinement statistics for the two models of hPEBP*.
Data set Native (soaked) Cacodylate-
bound
Resolution (Å) 20–2.05 20–1.75 
Highest resolution shell (Å) 2.15–2.05 1.83–1.75
Rcryst (%) 17.1 (16.1) 23.5 (26.8)
Rfree (%) 23.2 (23.0) 28.6 (32.2)
Root mean square deviation
bond lengths (Å) 0.008 0.009
bond angles (Å) 0.024 0.025
No. of nonhydrogen protein atoms 2908 2919
No. of solvent sites 394 241†
Average B value
mainchain (Å2) 13.5 23.0
sidechain (Å2) 14.9 24.0
solvent molecules (Å2) 25.0 29.6
*Numbers in parentheses represent the values for the highest
resolution shell. †Two cacodylate and 239 water molecules. 
Accession numbers
The coordinates and structure factors for the soaked native and cacody-
late-bound structures of hPEBP are available from the Brookhaven
Protein Data Bank, with accession codes 1BD9 (structure factors
R1BD9SF) and 1BEH (structure factors R1BEHSF), respectively.
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Figure 6
Ramachandran plot (prepared with MOLEMAN2 [31]) for the final
structure of hPEBP refined against the soaked native data. Of a total of
333 residues, 331 are found within the core regions, with only a single
outlier (residue Asp72 from both the A and B chains).
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